ROCK1 and gastric cancer: In conclusion, we have identified miRNA-135a as a new prognostic biomarker for LN metastasis in patients with EGC and demonstrated that miRNA-135a suppressed gastric carcinogenesis (i.e., proliferation, EMT, and metastasis in gastric cancer cell lines) by targeting ROCK1.